The Michael J. Fox Foundation has provided funding to inflammatory disease biotech Inflazome. The funding will support research intended to improve the chances that Inflazome will succeed in the clinic.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,